In the BioHarmony Drug Report Database

"Preview" Icon

Pilocarpine

Ocusert Pilo (pilocarpine) is a small molecule pharmaceutical. Pilocarpine was first approved as Ocusert Pilo on 1982-01-01. It is used to treat angle-closure glaucoma, head and neck neoplasms, mydriasis, and xerostomia in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, and cytochrome P450 2A6.

 

Trade Name

 

Ocusert Pilo
 

Common Name

 

pilocarpine
 

ChEMBL ID

 

CHEMBL550
 

Indication

 

angle-closure glaucoma, head and neck neoplasms, mydriasis, xerostomia
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Pilocarpine structure rendering